<iati-activities>
 <iati-activity default-currency="USD" dstore:dataset="usaid-ua" dstore:index="55" generated-datetime="2020-05-13T16:25:45.406Z" hierarchy="1" last-updated-datetime="2020-05-13T16:25:45.406Z" version="2.03" xml:lang="EN" xmlns:dstore="http://d-portal.org/xmlns/dstore" xmlns:usg="https://explorer.usaid.gov">
  <activity-date iso-date="2018-10-01" type="1"></activity-date>
  <activity-date iso-date="2018-10-01" type="2"></activity-date>
  <activity-date iso-date="2020-09-30" type="3"></activity-date>
  <activity-scope code="4"></activity-scope>
  <activity-status code="3"></activity-status>
  <collaboration-type code="1"></collaboration-type>
  <conditions attached="0"></conditions>
  <contact-info type="1">
   <email>aidtransparency@usaid.gov</email>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">Stephen Kelley</narrative>
   </person-name>
   <telephone>+1 202-567-4038</telephone>
   <website>https://www.usaid.gov/where-we-work/europe-and-eurasia/ukraine</website>
  </contact-info>
  <country-budget-items vocabulary="1"></country-budget-items>
  <crs-add>
   <loan-status currency="USD"></loan-status>
  </crs-add>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-finance-type code="110"></default-finance-type>
  <default-flow-type code="10"></default-flow-type>
  <default-tied-status code="4"></default-tied-status>
  <description>
   <narrative xml:lang="EN">Support scale up of diagnosis and treatment of MDR-TB, including measures to diagnose and treat extensively drug resistant TB and provide enhanced support for MDR-TB patients under treatment, improve clinical skills of providers to diagnose and treat MDR-TB, drug resistance surveillance, support clinical, operational and/or programmatic research related to MDR-TB, including late stage clinical trials to identify optimal MDR-TB treatment regimens. Note: See element HL.2.9 for guidance on infection control, which is often included in MDR-TB activities.</narrative>
  </description>
  <iati-identifier>US-GOV-1-72012119CA00002</iati-identifier>
  <participating-org role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org role="4" type="22">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Programmatic Management of Multi Drug-Resistant TB (MDR-TB)</narrative>
  </title>
  <transaction ref="EB198D5A381D">
   <disbursement-channel code="2"></disbursement-channel>
   <recipient-country code="UA"></recipient-country>
   <recipient-region vocabulary="1"></recipient-region>
   <sector code="12263" vocabulary="1">
    <narrative xml:lang="EN">Tuberculosis control</narrative>
   </sector>
   <sector code="3002" vocabulary="99">
    <narrative xml:lang="EN">Tuberculosis</narrative>
   </sector>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <transaction-type code="3"></transaction-type>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2019"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
   <value currency="USD" value-date="2019-12-31"></value>
  </transaction>
  <transaction ref="1C4161BAF7E5">
   <disbursement-channel code="2"></disbursement-channel>
   <recipient-country code="UA"></recipient-country>
   <recipient-region vocabulary="1"></recipient-region>
   <sector code="12263" vocabulary="1">
    <narrative xml:lang="EN">Tuberculosis control</narrative>
   </sector>
   <sector code="3002" vocabulary="99">
    <narrative xml:lang="EN">Tuberculosis</narrative>
   </sector>
   <transaction-date iso-date="2019-09-30"></transaction-date>
   <transaction-type code="2"></transaction-type>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2018" end="2019"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
   <value currency="USD" value-date="2019-09-30"></value>
  </transaction>
  <transaction ref="3A0652AE02CA">
   <description>
    <narrative xml:lang="EN">GLIDE: EP-2020-000012-001 (COVID-19)</narrative>
   </description>
   <disbursement-channel code="2"></disbursement-channel>
   <humanitarian-scope code="EP-2020-000012-001"></humanitarian-scope>
   <recipient-country code="UA"></recipient-country>
   <recipient-region vocabulary="1"></recipient-region>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3005" vocabulary="99">
    <narrative xml:lang="EN">Other Public Health Threats</narrative>
   </sector>
   <transaction-date iso-date="2020-04-30"></transaction-date>
   <transaction-type code="2"></transaction-type>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2020" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
   <value currency="USD" value-date="2020-04-30"></value>
  </transaction>
  <usg:duns-number>
   <narrative>103713624</narrative>
  </usg:duns-number>
  <usg:mechanism-signing-date iso-date="2019-10-01"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Ukraine</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>19499451.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
